GP accused of racism secures legal win over $364,000 supervision order
A GP accused of making racist and homophobic comments to patients has won his case to have supervision requirements lifted, with a tribunal finding they…
Tag: LGBTQI
Why detransition became an untouchable subject in gender care: special report
The public debate on the rights and wrongs of gender-affirming care is often reduced to the small number of patients who decide to detransition. The…
NHS bans routine use of puberty blockers for gender dysphoria amid safety concerns
NHS England has banned the “routine” prescription of puberty blockers for children and young people with gender dysphoria, claiming there is insufficient evidence of their safety. The decision,…
How many patients re-identify with their birth-registered sex? Rare findings from an Aussie gender clinic
This morning saw the release in JAMA Pediatrics of a new study looking at young patients referred to one of Australia’s state-funded paediatric gender clinics.…
How an Aussie study on transgender ‘desistance’ rates became a culture war flashpoint
A group of doctors at The Children’s Hospital at Westmead in Sydney made headlines last year following the publication of their research paper in an…
The curious case of the ‘de-sexing’ of clinical language and the Attorney-General
The de-sexing of medical language has sparked debate this week, after 180 clinicians and researchers warned the NHMRC of its clinical dangers. Responding to two…
‘De-sexing’ of medical language is harming patients, NHMRC warned
The de-sexing of medical language is perpetuating anti-women bias in research and putting transgender patients’ safety at greater risk, a group of clinicians and researchers…
Bone density loss from puberty blockers ‘reversible’ in transgender patients
Bone density loss in teenagers with gender dysphoria prescribed puberty blockers is mostly reversible with long-term gender-affirming hormone treatment in adulthood, Dutch doctors report in a…
PBAC approves long-acting injectable PrEP for HIV
Patients with contraindications to daily oral HIV pre-exposure prophylaxis could soon access a PBS-subsidised long-acting injectable. Following its September meeting, the PBAC has recommended a…
Consider doxy-PEP as morning after pill for syphilis prevention, doctors say
Leading sexual health physicians have cautiously backed the use of doxycycline as a morning after pill for STI prevention in high-risk gay and bisexual men.…
